ASX CODE: CUV

Clinuvel Pharmaceuticals ASX CUV FDA approval Scenesse genetic disorder US Food and Drug Administration

Clinuvel Pharmaceuticals offers up novel drug to combat rare genetic disease following FDA approval

Clinuvel Pharmaceuticals (ASX: CUV) has been given the all-clear to market its afamelanotide drug (brand-named Scenesse) by the US Food and Drug Administration (FDA). The...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS